| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Otolaryngology-Head and Neck Surgery, Division of Head and Neck Cancer Research [K. H., L. W., D. S., J. J.], Departments of Oncology [S. B., S. R. H., D. S., J. J.] and Pathology [C. R. R., S. R. H.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196
We have searched for the presence of genetic alterations in serum DNA obtained from 44 colorectal cancer patients. Microsatellite analysis using highly polymorphic markers revealed loss of heterozygosity and/or microsatellite instability in 35 of 44 (80%) primary tumors. No alterations were detected in the paired serum DNA. We next used an oligonucleotide-mediated mismatch ligation assay to detect tumor specific gene mutations in the serum. Among the 16 cases with a K-ras gene mutation in the tumor, the same mutation was detected in three paired serum samples. In the 10 cases with a p53 mutation in the tumor, the identical mutation was detected in seven corresponding serum samples. Comparison of the molecular analysis with clinical diagnosis of these patients revealed that none of the seven Dukes' stage B patients with a K-ras mutation in their tumors demonstrated a mutation in the serum. In contrast, five of seven stage B patients with a p53 mutation in the tumor demonstrated a mutation in the paired serum (P = 0.01, Fisher's exact test). Taken together, either a K-ras or p53 mutation was detected in the serum in 40% of the 25 patients (95% confidence interval, 21–61%), whose primary tumors contained a mutation and in 23% of the 44 patients (95% confidence interval, 12–38%) with colorectal cancer. The frequent detection of p53 mutation in the serum of patients with early stage tumors suggests a possible use of this approach for clinical prognosis and cancer monitoring of colorectal cancer patients.
1 Supported in part by NIH Grant CA62924 and an award to J. J. from the James Valvano Foundation.
2 To whom requests for reprints should be addressed, at Johns Hopkins University School of Medicine, 824 Ross Research Building, 720 Rutland Avenue, Baltimore, MD 21205-2196.
Received 1/ 7/98. Accepted 2/16/98.
This article has been cited by other articles:
|
|
 |
|
  Y.-H. KITAMURA, A. SHIRAHATA, M. SAKATA, T. GOTO, H. MIZUKAMI, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, Y. SANADA, et al. Frequent Methylation of Vimentin in Well-differentiated Gastric Carcinoma Anticancer Res, June 1, 2009; 29(6): 2227 - 2229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. SAKATA, Y.-H. KITAMURA, K. SAKURABA, T. GOTO, H. MIZUKAMI, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, Y. SANADA, et al. Methylation of HACE1 in Gastric Carcinoma Anticancer Res, June 1, 2009; 29(6): 2231 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. SHIRAHATA, M. SAKATA, K. SAKURABA, T. GOTO, H. MIZUKAMI, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, Y. SANADA, et al. Vimentin Methylation as a Marker for Advanced Colorectal Carcinoma Anticancer Res, January 1, 2009; 29(1): 279 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Muller, C. Beeger, C. Alix-Panabieres, X. Rebillard, K. Pantel, and H. Schwarzenbach Identification of Loss of Heterozygosity on Circulating Free DNA in Peripheral Blood of Prostate Cancer Patients: Potential and Technical Improvements Clin. Chem., April 1, 2008; 54(4): 688 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hagiwara, L. E. Mechanic, G. E. Trivers, H. L. Cawley, M. Taga, E. D. Bowman, K. Kumamoto, P. He, M. Bernard, S. Doja, et al. Quantitative Detection of p53 Mutations in Plasma DNA from Tobacco Smokers Cancer Res., August 15, 2006; 66(16): 8309 - 8317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, L. Harris, H. Mamon, M. H. Kulke, W.-H. Liu, P. Zhu, and G. Mike Makrigiorgos Whole Genome Amplification of Plasma-Circulating DNA Enables Expanded Screening for Allelic Imbalance in Plasma J. Mol. Diagn., February 1, 2006; 8(1): 22 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Busby and A Morris Detection of BRAF mutations in colorectal tumours and peritoneal washings using a mismatch ligation assay J. Clin. Pathol., April 1, 2005; 58(4): 372 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Glick and L. A. Loeb Mitochondrial DNA and Cancer Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 267 - 270. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujiwara, N. Fujimoto, M. Tabata, K. Nishii, K. Matsuo, K. Hotta, T. Kozuki, M. Aoe, K. Kiura, H. Ueoka, et al. Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung Cancer Clin. Cancer Res., February 1, 2005; 11(3): 1219 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Halperin, A. Buhot, and E. B. Zhulina Hybridization Isotherms of DNA Microarrays and the Quantification of Mutation Studies Clin. Chem., December 1, 2004; 50(12): 2254 - 2262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. I. de Caceres, C. Battagli, M. Esteller, J. G. Herman, E. Dulaimi, M. I. Edelson, C. Bergman, H. Ehya, B. L. Eisenberg, and P. Cairns Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients Cancer Res., September 15, 2004; 64(18): 6476 - 6481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dulaimi, J. Hillinck, I. I. de Caceres, T. Al-Saleem, and P. Cairns Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients Clin. Cancer Res., September 15, 2004; 10(18): 6189 - 6193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Atamaniuk, C. Vidotto, H. Tschan, N. Bachl, K. M. Stuhlmeier, and M. M. Muller Increased Concentrations of Cell-Free Plasma DNA after Exhaustive Exercise Clin. Chem., September 1, 2004; 50(9): 1668 - 1670. [Full Text] [PDF]
|
|
|
|
|
|
A M Gilbey, D Burnett, R E Coleman, and I Holen The detection of circulating breast cancer cells in blood J. Clin. Pathol., September 1, 2004; 57(9): 903 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. El-Hefnawy, S. Raja, L. Kelly, W. L. Bigbee, J. M. Kirkwood, J. D. Luketich, and T. E. Godfrey Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics Clin. Chem., March 1, 2004; 50(3): 564 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Eisenberger, W. T. Knoefel, M. Peiper, P. Merkert, E. F. Yekebas, P. Scheunemann, K. Steffani, N. H. Stoecklein, S. B. Hosch, and J. R. Izbicki Squamous Cell Carcinoma of the Esophagus Can Be Detected by Microsatellite Analysis in Tumor and Serum Clin. Cancer Res., September 15, 2003; 9(11): 4178 - 4183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Taback, A. E. Giuliano, N. M. Hansen, F. R. Singer, S. Shu, and D. S. B. Hoon Detection of Tumor-Specific Genetic Alterations in Bone Marrow from Early-Stage Breast Cancer Patients Cancer Res., April 15, 2003; 63(8): 1884 - 1887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Okochi, K. Hibi, T. Uemura, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao Detection of Mitochondrial DNA Alterations in the Serum of Hepatocellular Carcinoma Patients Clin. Cancer Res., September 1, 2002; 8(9): 2875 - 2878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koike, K. Hibi, Y. Kasai, K. Ito, S. Akiyama, and A. Nakao Molecular Detection of Circulating Esophageal Squamous Cell Cancer Cells in the Peripheral Blood Clin. Cancer Res., September 1, 2002; 8(9): 2879 - 2882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-L. Lee, W. K. Leung, M. W. Y. Chan, E. K. W. Ng, J. H. M. Tong, K.-W. Lo, S. C. S. Chung, J. J. Y. Sung, and K.-F. To Detection of Gene Promoter Hypermethylation in the Tumor and Serum of Patients with Gastric Carcinoma Clin. Cancer Res., June 1, 2002; 8(6): 1761 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Silva, R Rodriguez, J M Garcia, C Munoz, J Silva, G Dominguez, M Provencio, P Espana, and F Bonilla Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells Gut, April 1, 2002; 50(4): 530 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. C. Ngan, T. T. C. Yip, W.-W. Cheng, J. K. C. Chan, W. C. S. Cho, V. W. S. Ma, K.-K. Wan, S.-K. Au, C.-K. Law, and W.-H. Lau Circulating Epstein-Barr Virus DNA in Serum of Patients with Lymphoepithelioma-like Carcinoma of the Lung: A Potential Surrogate Marker for Monitoring Disease Clin. Cancer Res., April 1, 2002; 8(4): 986 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Usadel, J. Brabender, K. D. Danenberg, C. Jeronimo, S. Harden, J. Engles, P. V. Danenberg, S. Yang, and D. Sidransky Quantitative Adenomatous Polyposis Coli Promoter Methylation Analysis in Tumor Tissue, Serum, and Plasma DNA of Patients with Lung Cancer Cancer Res., January 1, 2002; 62(2): 371 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Z. Zou, B.-M. Yu, Z.-W. Wang, J.-Y. Sun, H. Cang, F. Gao, D. H. Li, R. Zhao, G.-G. Feng, and J. Yi Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients Clin. Cancer Res., January 1, 2002; 8(1): 188 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Silva, F. Bonilla, H. Blons, F. Coulet, and P. Laurent-Puig Correspondence re: F. Coulet et al., Detection of Plasma Tumor DNA in Head and Neck Squamous Cell Carcinoma by Microsatellite Typing and p53 Mutation Analysis. Cancer Res., 60: 707-709, 2000. Cancer Res., December 1, 2001; 61(23): 8595 - 8596. [Full Text] [PDF]
|
|
|
|
|
|
K. Hibi, M. Taguchi, H. Nakayama, T. Takase, Y. Kasai, K. Ito, S. Akiyama, and A. Nakao Molecular Detection of p16 Promoter Methylation in the Serum of Patients with Esophageal Squamous Cell Carcinoma Clin. Cancer Res., October 1, 2001; 7(10): 3135 - 3138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Silva, G. Dominguez, J. Silva, J. M. Garcia, A. Sanchez, O. Rodriguez, M. Provencio, P. Espana, and F. Bonilla Detection of Epithelial Messenger RNA in the Plasma of Breast Cancer Patients Is Associated with Poor Prognosis Tumor Characteristics Clin. Cancer Res., September 1, 2001; 7(9): 2821 - 2825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tortola, R. Steinert, M. Hantschick, M. A. Peinado, I. Gastinger, P. Stosiek, H. Lippert, W. Schlegel, and M. A. Reymond Discordance Between K-ras Mutations in Bone Marrow Micrometastases and the Primary Tumor in Colorectal Cancer J. Clin. Oncol., June 1, 2001; 19(11): 2837 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Grady, A. Rajput, J. D. Lutterbaugh, and S. D. Markowitz Detection of Aberrantly Methylated hMLH1 Promoter DNA in the Serum of Patients with Microsatellite Unstable Colon Cancer Cancer Res., February 1, 2001; 61(3): 900 - 902. [Abstract] [Full Text]
|
|
|
|
|
|
T. Liloglou, P. Maloney, G. Xinarianos, M. Hulbert, M. J. Walshaw, J. R. Gosney, L. Turnbull, and J. K. Field Cancer-specific Genomic Instability in Bronchial Lavage: A Molecular Tool for Lung Cancer Detection Cancer Res., February 1, 2001; 61(4): 1624 - 1628. [Abstract] [Full Text]
|
|
|
|
|
|
E. Lopez-Crapez, T. Livache, J. Marchand, and J. Grenier K-ras Mutation Detection by Hybridization to a Polypyrrole DNA Chip Clin. Chem., February 1, 2001; 47(2): 186 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr. Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Kawakami, J. Brabender, R. V. Lord, S. Groshen, B. D. Greenwald, M. J. Krasna, J. Yin, A. S. Fleisher, J. M. Abraham, D. G. Beer, et al. Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma J Natl Cancer Inst, November 15, 2000; 92(22): 1805 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ashida, H. Okuda, M. Chikazawa, M. Tanimura, O. Sugita, Y. Yamamoto, S. Nakamura, M. Moriyama, and T. Shuin Detection of Circulating Cancer Cells with von Hippel-Lindau Gene Mutation in Peripheral Blood of Patients with Renal Cell Carcinoma Clin. Cancer Res., October 1, 2000; 6(10): 3817 - 3822. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Kopreski, F. A. Benko, D. J. Borys, A. Khan, T. J. McGarrity, and C. D. Gocke Somatic Mutation Screening: Identification of Individuals Harboring K-ras Mutations With the Use of Plasma DNA J Natl Cancer Inst, June 7, 2000; 92(11): 918 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Sorenson Detection of Mutated KRAS2 Sequences as Tumor Markers in Plasma/Serum of Patients with Gastrointestinal Cancer Clin. Cancer Res., June 1, 2000; 6(6): 2129 - 2137. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Hibi, B. Trink, M. Patturajan, W. H. Westra, O. L. Caballero, D. E. Hill, E. A. Ratovitski, J. Jen, and D. Sidransky AIS is an oncogene amplified in squamous cell carcinoma PNAS, May 9, 2000; 97(10): 5462 - 5467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shotelersuk, C. Khorprasert, S. Sakdikul, W. Pornthanakasem, N. Voravud, and A. Mutirangura Epstein-Barr Virus DNA in Serum/Plasma as a Tumor Marker for Nasopharyngeal Cancer Clin. Cancer Res., March 1, 2000; 6(3): 1046 - 1051. [Abstract] [Full Text]
|
|
|
|
|
|
F. Coulet, H. Blons, A. Cabelguenne, T. Lecomte, O. Laccourreye, D. Brasnu, P. Beaune, J. Zucman, and P. Laurent-Puig Detection of Plasma Tumor DNA in Head and Neck Squamous Cell Carcinoma by Microsatellite Typing and p53 Mutation Analysis Cancer Res., February 1, 2000; 60(3): 707 - 711. [Abstract] [Full Text]
|
|
|
|
|
|
M. Sanchez-Cespedes, M. Esteller, L. Wu, H. Nawroz-Danish, G. H. Yoo, W. M. Koch, J. Jen, J. G. Herman, and D. Sidransky Gene Promoter Hypermethylation in Tumors and Serum of Head and Neck Cancer Patients Cancer Res., February 1, 2000; 60(4): 892 - 895. [Abstract] [Full Text]
|
|
|
|
|
|
X. q. Chen, H. Bonnefoi, S. Diebold-Berger, J. Lyautey, C. Lederrey, E. Faltin-Traub, M. Stroun, and P. Anker Detecting Tumor-related Alterations in Plasma or Serum DNA of Patients Diagnosed with Breast Cancer Clin. Cancer Res., September 1, 1999; 5(9): 2297 - 2303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sanchez-Cespedes, M. Esteller, K. Hibi, F. O. Cope, W. H. Westra, S. Piantadosi, J. G. Herman, J. Jen, and D. Sidransky Molecular Detection of Neoplastic Cells in Lymph Nodes of Metastatic Colorectal Cancer Patients Predicts Recurrence Clin. Cancer Res., September 1, 1999; 5(9): 2450 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kopreski, F. A. Benko, L. W. Kwak, and C. D. Gocke Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma Clin. Cancer Res., August 1, 1999; 5(8): 1961 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Parrella, D. Sidransky, and S. L. Merbs Allelotype of Posterior Uveal Melanoma: Implications for a Bifurcated Tumor Progression Pathway Cancer Res., July 1, 1999; 59(13): 3032 - 3037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Silva, G. Dominguez, J. M. Garcia, R. Gonzalez, M. J. Villanueva, F. Navarro, M. Provencio, S. San Martin, P. Espana, and F. Bonilla Presence of Tumor DNA in Plasma of Breast Cancer Patients: Clinicopathological Correlations Cancer Res., July 1, 1999; 59(13): 3251 - 3256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-W. Chiang, D. G. Beer, W.-L. Wei, M. B. Orringer, and D. M. Kurnit Detection of erbB-2 Amplifications in Tumors and Sera from Esophageal Carcinoma Patients Clin. Cancer Res., June 1, 1999; 5(6): 1381 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.M. D. Lo, T. N. Leung, M. S.C. Tein, I. L. Sargent, J. Zhang, T. K. Lau, C. J. Haines, and C. W.G. Redman Quantitative Abnormalities of Fetal DNA in Maternal Serum in Preeclampsia Clin. Chem., February 1, 1999; 45(2): 184 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller, M. Sanchez-Cespedes, R. Rosell, D. Sidransky, S. B. Baylin, and J. G. Herman Detection of Aberrant Promoter Hypermethylation of Tumor Suppressor Genes in Serum DNA from Non-Small Cell Lung Cancer Patients Cancer Res., January 1, 1999; 59(1): 67 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. N. Wong, Y. M. Dennis Lo, J. Zhang, C.-T. Liew, M. H. L. Ng, N. Wong, P. B. S. Lai, W. Y. Lau, N. M. Hjelm, and P. J. Johnson Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients Cancer Res., January 1, 1999; 59(1): 71 - 73. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
